SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the ...
CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, ...
SPR Therapeutics, a Cleveland medical device company, has secured $85 million in financing to advance the commercial expansion of its SPRINT PNS System, a non-opioid, minimally invasive pain treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback